nodes	percent_of_prediction	percent_of_DWPC	metapath
Gemcitabine—TYMS—Methotrexate—ankylosing spondylitis	0.281	0.366	CbGbCtD
Gemcitabine—ABCC10—Methotrexate—ankylosing spondylitis	0.231	0.302	CbGbCtD
Gemcitabine—ABCB1—Methylprednisolone—ankylosing spondylitis	0.0709	0.0926	CbGbCtD
Gemcitabine—ABCB1—Betamethasone—ankylosing spondylitis	0.0461	0.0602	CbGbCtD
Gemcitabine—ABCB1—Prednisolone—ankylosing spondylitis	0.0455	0.0594	CbGbCtD
Gemcitabine—ABCB1—Prednisone—ankylosing spondylitis	0.043	0.0561	CbGbCtD
Gemcitabine—ABCB1—Dexamethasone—ankylosing spondylitis	0.0268	0.035	CbGbCtD
Gemcitabine—ABCB1—Methotrexate—ankylosing spondylitis	0.0215	0.0281	CbGbCtD
Gemcitabine—POLD1—Danazol—Prednisone—ankylosing spondylitis	0.000813	0.0686	CbGdCrCtD
Gemcitabine—Haemorrhage—Betamethasone—ankylosing spondylitis	0.000499	0.00224	CcSEcCtD
Gemcitabine—Haemorrhage—Dexamethasone—ankylosing spondylitis	0.000499	0.00224	CcSEcCtD
Gemcitabine—Angiopathy—Methylprednisolone—ankylosing spondylitis	0.000498	0.00224	CcSEcCtD
Gemcitabine—Immune system disorder—Methylprednisolone—ankylosing spondylitis	0.000495	0.00223	CcSEcCtD
Gemcitabine—Mediastinal disorder—Methylprednisolone—ankylosing spondylitis	0.000494	0.00222	CcSEcCtD
Gemcitabine—Arrhythmia—Triamcinolone—ankylosing spondylitis	0.000491	0.00221	CcSEcCtD
Gemcitabine—Arrhythmia—Methylprednisolone—ankylosing spondylitis	0.00049	0.0022	CcSEcCtD
Gemcitabine—Hyperglycaemia—Prednisone—ankylosing spondylitis	0.00049	0.0022	CcSEcCtD
Gemcitabine—Liver function test abnormal—Methotrexate—ankylosing spondylitis	0.000484	0.00218	CcSEcCtD
Gemcitabine—Ill-defined disorder—Prednisolone—ankylosing spondylitis	0.000483	0.00217	CcSEcCtD
Gemcitabine—Erythema—Triamcinolone—ankylosing spondylitis	0.000479	0.00215	CcSEcCtD
Gemcitabine—Erythema—Methylprednisolone—ankylosing spondylitis	0.000477	0.00215	CcSEcCtD
Gemcitabine—Acute coronary syndrome—Prednisone—ankylosing spondylitis	0.000477	0.00214	CcSEcCtD
Gemcitabine—Myocardial infarction—Prednisone—ankylosing spondylitis	0.000474	0.00213	CcSEcCtD
Gemcitabine—Neuropathy peripheral—Prednisone—ankylosing spondylitis	0.000474	0.00213	CcSEcCtD
Gemcitabine—Toxic epidermal necrolysis—Methotrexate—ankylosing spondylitis	0.000473	0.00212	CcSEcCtD
Gemcitabine—Malaise—Prednisolone—ankylosing spondylitis	0.000469	0.00211	CcSEcCtD
Gemcitabine—Back pain—Triamcinolone—ankylosing spondylitis	0.000463	0.00208	CcSEcCtD
Gemcitabine—Angiopathy—Dexamethasone—ankylosing spondylitis	0.000453	0.00203	CcSEcCtD
Gemcitabine—Angiopathy—Betamethasone—ankylosing spondylitis	0.000453	0.00203	CcSEcCtD
Gemcitabine—Hypertension—Prednisolone—ankylosing spondylitis	0.000449	0.00202	CcSEcCtD
Gemcitabine—Arrhythmia—Dexamethasone—ankylosing spondylitis	0.000446	0.002	CcSEcCtD
Gemcitabine—Arrhythmia—Betamethasone—ankylosing spondylitis	0.000446	0.002	CcSEcCtD
Gemcitabine—Ill-defined disorder—Triamcinolone—ankylosing spondylitis	0.000444	0.002	CcSEcCtD
Gemcitabine—Ill-defined disorder—Methylprednisolone—ankylosing spondylitis	0.000443	0.00199	CcSEcCtD
Gemcitabine—Alopecia—Dexamethasone—ankylosing spondylitis	0.000441	0.00198	CcSEcCtD
Gemcitabine—Alopecia—Betamethasone—ankylosing spondylitis	0.000441	0.00198	CcSEcCtD
Gemcitabine—Discomfort—Prednisolone—ankylosing spondylitis	0.000438	0.00197	CcSEcCtD
Gemcitabine—Haemoglobin—Prednisone—ankylosing spondylitis	0.000437	0.00196	CcSEcCtD
Gemcitabine—Haemorrhage—Prednisone—ankylosing spondylitis	0.000434	0.00195	CcSEcCtD
Gemcitabine—Erythema—Betamethasone—ankylosing spondylitis	0.000434	0.00195	CcSEcCtD
Gemcitabine—Erythema—Dexamethasone—ankylosing spondylitis	0.000434	0.00195	CcSEcCtD
Gemcitabine—Malaise—Triamcinolone—ankylosing spondylitis	0.000432	0.00194	CcSEcCtD
Gemcitabine—Pancytopenia—Methotrexate—ankylosing spondylitis	0.000431	0.00194	CcSEcCtD
Gemcitabine—Malaise—Methylprednisolone—ankylosing spondylitis	0.000431	0.00194	CcSEcCtD
Gemcitabine—Connective tissue disorder—Prednisone—ankylosing spondylitis	0.000427	0.00192	CcSEcCtD
Gemcitabine—Oedema—Prednisolone—ankylosing spondylitis	0.000425	0.00191	CcSEcCtD
Gemcitabine—Anaphylactic shock—Prednisolone—ankylosing spondylitis	0.000425	0.00191	CcSEcCtD
Gemcitabine—Neutropenia—Methotrexate—ankylosing spondylitis	0.000424	0.00191	CcSEcCtD
Gemcitabine—Cough—Triamcinolone—ankylosing spondylitis	0.000418	0.00188	CcSEcCtD
Gemcitabine—Hypertension—Triamcinolone—ankylosing spondylitis	0.000413	0.00186	CcSEcCtD
Gemcitabine—Hypertension—Methylprednisolone—ankylosing spondylitis	0.000412	0.00185	CcSEcCtD
Gemcitabine—Hyperhidrosis—Prednisolone—ankylosing spondylitis	0.000411	0.00185	CcSEcCtD
Gemcitabine—Myalgia—Triamcinolone—ankylosing spondylitis	0.000407	0.00183	CcSEcCtD
Gemcitabine—Pneumonia—Methotrexate—ankylosing spondylitis	0.000407	0.00183	CcSEcCtD
Gemcitabine—Myalgia—Methylprednisolone—ankylosing spondylitis	0.000406	0.00183	CcSEcCtD
Gemcitabine—Arthralgia—Methylprednisolone—ankylosing spondylitis	0.000406	0.00183	CcSEcCtD
Gemcitabine—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—ankylosing spondylitis	0.000404	0.00181	CcSEcCtD
Gemcitabine—Ill-defined disorder—Dexamethasone—ankylosing spondylitis	0.000403	0.00181	CcSEcCtD
Gemcitabine—Ill-defined disorder—Betamethasone—ankylosing spondylitis	0.000403	0.00181	CcSEcCtD
Gemcitabine—Discomfort—Triamcinolone—ankylosing spondylitis	0.000402	0.00181	CcSEcCtD
Gemcitabine—Discomfort—Methylprednisolone—ankylosing spondylitis	0.000402	0.0018	CcSEcCtD
Gemcitabine—Stevens-Johnson syndrome—Methotrexate—ankylosing spondylitis	0.000401	0.0018	CcSEcCtD
Gemcitabine—Renal failure—Methotrexate—ankylosing spondylitis	0.000397	0.00179	CcSEcCtD
Gemcitabine—Stomatitis—Methotrexate—ankylosing spondylitis	0.000394	0.00177	CcSEcCtD
Gemcitabine—Angiopathy—Prednisone—ankylosing spondylitis	0.000394	0.00177	CcSEcCtD
Gemcitabine—Immune system disorder—Prednisone—ankylosing spondylitis	0.000392	0.00176	CcSEcCtD
Gemcitabine—Malaise—Dexamethasone—ankylosing spondylitis	0.000392	0.00176	CcSEcCtD
Gemcitabine—Malaise—Betamethasone—ankylosing spondylitis	0.000392	0.00176	CcSEcCtD
Gemcitabine—Oedema—Triamcinolone—ankylosing spondylitis	0.000391	0.00176	CcSEcCtD
Gemcitabine—Anaphylactic shock—Triamcinolone—ankylosing spondylitis	0.000391	0.00176	CcSEcCtD
Gemcitabine—Anaphylactic shock—Methylprednisolone—ankylosing spondylitis	0.00039	0.00175	CcSEcCtD
Gemcitabine—Arrhythmia—Prednisone—ankylosing spondylitis	0.000388	0.00174	CcSEcCtD
Gemcitabine—Infection—Triamcinolone—ankylosing spondylitis	0.000388	0.00174	CcSEcCtD
Gemcitabine—Sweating—Methotrexate—ankylosing spondylitis	0.000388	0.00174	CcSEcCtD
Gemcitabine—Infection—Methylprednisolone—ankylosing spondylitis	0.000387	0.00174	CcSEcCtD
Gemcitabine—Haematuria—Methotrexate—ankylosing spondylitis	0.000386	0.00173	CcSEcCtD
Gemcitabine—Insomnia—Prednisolone—ankylosing spondylitis	0.000384	0.00173	CcSEcCtD
Gemcitabine—Alopecia—Prednisone—ankylosing spondylitis	0.000384	0.00173	CcSEcCtD
Gemcitabine—Hepatobiliary disease—Methotrexate—ankylosing spondylitis	0.000382	0.00172	CcSEcCtD
Gemcitabine—Nervous system disorder—Methylprednisolone—ankylosing spondylitis	0.000382	0.00172	CcSEcCtD
Gemcitabine—Paraesthesia—Prednisolone—ankylosing spondylitis	0.000381	0.00171	CcSEcCtD
Gemcitabine—Skin disorder—Methylprednisolone—ankylosing spondylitis	0.000378	0.0017	CcSEcCtD
Gemcitabine—Erythema—Prednisone—ankylosing spondylitis	0.000378	0.0017	CcSEcCtD
Gemcitabine—Hyperhidrosis—Triamcinolone—ankylosing spondylitis	0.000378	0.0017	CcSEcCtD
Gemcitabine—Agranulocytosis—Methotrexate—ankylosing spondylitis	0.000377	0.0017	CcSEcCtD
Gemcitabine—Hyperhidrosis—Methylprednisolone—ankylosing spondylitis	0.000377	0.00169	CcSEcCtD
Gemcitabine—Hypertension—Dexamethasone—ankylosing spondylitis	0.000375	0.00168	CcSEcCtD
Gemcitabine—Hypertension—Betamethasone—ankylosing spondylitis	0.000375	0.00168	CcSEcCtD
Gemcitabine—Myalgia—Dexamethasone—ankylosing spondylitis	0.00037	0.00166	CcSEcCtD
Gemcitabine—Myalgia—Betamethasone—ankylosing spondylitis	0.00037	0.00166	CcSEcCtD
Gemcitabine—Discomfort—Betamethasone—ankylosing spondylitis	0.000365	0.00164	CcSEcCtD
Gemcitabine—Discomfort—Dexamethasone—ankylosing spondylitis	0.000365	0.00164	CcSEcCtD
Gemcitabine—Haemoglobin—Methotrexate—ankylosing spondylitis	0.000365	0.00164	CcSEcCtD
Gemcitabine—Hypotension—Methylprednisolone—ankylosing spondylitis	0.000364	0.00164	CcSEcCtD
Gemcitabine—Pain—Prednisolone—ankylosing spondylitis	0.000363	0.00163	CcSEcCtD
Gemcitabine—Haemorrhage—Methotrexate—ankylosing spondylitis	0.000363	0.00163	CcSEcCtD
Gemcitabine—Pharyngitis—Methotrexate—ankylosing spondylitis	0.00036	0.00162	CcSEcCtD
Gemcitabine—Urinary tract disorder—Methotrexate—ankylosing spondylitis	0.000358	0.00161	CcSEcCtD
Gemcitabine—Urethral disorder—Methotrexate—ankylosing spondylitis	0.000356	0.0016	CcSEcCtD
Gemcitabine—Musculoskeletal discomfort—Triamcinolone—ankylosing spondylitis	0.000356	0.0016	CcSEcCtD
Gemcitabine—Musculoskeletal discomfort—Methylprednisolone—ankylosing spondylitis	0.000355	0.0016	CcSEcCtD
Gemcitabine—Oedema—Dexamethasone—ankylosing spondylitis	0.000354	0.00159	CcSEcCtD
Gemcitabine—Anaphylactic shock—Dexamethasone—ankylosing spondylitis	0.000354	0.00159	CcSEcCtD
Gemcitabine—Oedema—Betamethasone—ankylosing spondylitis	0.000354	0.00159	CcSEcCtD
Gemcitabine—Anaphylactic shock—Betamethasone—ankylosing spondylitis	0.000354	0.00159	CcSEcCtD
Gemcitabine—Insomnia—Triamcinolone—ankylosing spondylitis	0.000353	0.00159	CcSEcCtD
Gemcitabine—Insomnia—Methylprednisolone—ankylosing spondylitis	0.000352	0.00158	CcSEcCtD
Gemcitabine—Infection—Betamethasone—ankylosing spondylitis	0.000352	0.00158	CcSEcCtD
Gemcitabine—Infection—Dexamethasone—ankylosing spondylitis	0.000352	0.00158	CcSEcCtD
Gemcitabine—Ill-defined disorder—Prednisone—ankylosing spondylitis	0.000351	0.00158	CcSEcCtD
Gemcitabine—Paraesthesia—Triamcinolone—ankylosing spondylitis	0.000351	0.00158	CcSEcCtD
Gemcitabine—Feeling abnormal—Prednisolone—ankylosing spondylitis	0.00035	0.00157	CcSEcCtD
Gemcitabine—Paraesthesia—Methylprednisolone—ankylosing spondylitis	0.00035	0.00157	CcSEcCtD
Gemcitabine—Anaemia—Prednisone—ankylosing spondylitis	0.000349	0.00157	CcSEcCtD
Gemcitabine—Dyspnoea—Triamcinolone—ankylosing spondylitis	0.000348	0.00156	CcSEcCtD
Gemcitabine—Nervous system disorder—Betamethasone—ankylosing spondylitis	0.000348	0.00156	CcSEcCtD
Gemcitabine—Nervous system disorder—Dexamethasone—ankylosing spondylitis	0.000348	0.00156	CcSEcCtD
Gemcitabine—Thrombocytopenia—Dexamethasone—ankylosing spondylitis	0.000347	0.00156	CcSEcCtD
Gemcitabine—Thrombocytopenia—Betamethasone—ankylosing spondylitis	0.000347	0.00156	CcSEcCtD
Gemcitabine—Erythema multiforme—Methotrexate—ankylosing spondylitis	0.000343	0.00154	CcSEcCtD
Gemcitabine—Hyperhidrosis—Dexamethasone—ankylosing spondylitis	0.000343	0.00154	CcSEcCtD
Gemcitabine—Hyperhidrosis—Betamethasone—ankylosing spondylitis	0.000343	0.00154	CcSEcCtD
Gemcitabine—Malaise—Prednisone—ankylosing spondylitis	0.000341	0.00153	CcSEcCtD
Gemcitabine—Anorexia—Dexamethasone—ankylosing spondylitis	0.000338	0.00152	CcSEcCtD
Gemcitabine—Anorexia—Betamethasone—ankylosing spondylitis	0.000338	0.00152	CcSEcCtD
Gemcitabine—Cardiac disorder—Methotrexate—ankylosing spondylitis	0.000337	0.00151	CcSEcCtD
Gemcitabine—Fatigue—Triamcinolone—ankylosing spondylitis	0.000337	0.00151	CcSEcCtD
Gemcitabine—Fatigue—Methylprednisolone—ankylosing spondylitis	0.000336	0.00151	CcSEcCtD
Gemcitabine—Pain—Triamcinolone—ankylosing spondylitis	0.000334	0.0015	CcSEcCtD
Gemcitabine—Hypotension—Dexamethasone—ankylosing spondylitis	0.000331	0.00149	CcSEcCtD
Gemcitabine—Hypotension—Betamethasone—ankylosing spondylitis	0.000331	0.00149	CcSEcCtD
Gemcitabine—Angiopathy—Methotrexate—ankylosing spondylitis	0.000329	0.00148	CcSEcCtD
Gemcitabine—Immune system disorder—Methotrexate—ankylosing spondylitis	0.000328	0.00147	CcSEcCtD
Gemcitabine—Mediastinal disorder—Methotrexate—ankylosing spondylitis	0.000327	0.00147	CcSEcCtD
Gemcitabine—Hypertension—Prednisone—ankylosing spondylitis	0.000326	0.00147	CcSEcCtD
Gemcitabine—Chills—Methotrexate—ankylosing spondylitis	0.000326	0.00146	CcSEcCtD
Gemcitabine—Musculoskeletal discomfort—Betamethasone—ankylosing spondylitis	0.000323	0.00145	CcSEcCtD
Gemcitabine—Musculoskeletal discomfort—Dexamethasone—ankylosing spondylitis	0.000323	0.00145	CcSEcCtD
Gemcitabine—Arthralgia—Prednisone—ankylosing spondylitis	0.000322	0.00145	CcSEcCtD
Gemcitabine—Myalgia—Prednisone—ankylosing spondylitis	0.000322	0.00145	CcSEcCtD
Gemcitabine—Feeling abnormal—Triamcinolone—ankylosing spondylitis	0.000322	0.00145	CcSEcCtD
Gemcitabine—Feeling abnormal—Methylprednisolone—ankylosing spondylitis	0.000321	0.00144	CcSEcCtD
Gemcitabine—Alopecia—Methotrexate—ankylosing spondylitis	0.000321	0.00144	CcSEcCtD
Gemcitabine—Insomnia—Betamethasone—ankylosing spondylitis	0.00032	0.00144	CcSEcCtD
Gemcitabine—Insomnia—Dexamethasone—ankylosing spondylitis	0.00032	0.00144	CcSEcCtD
Gemcitabine—Unspecified disorder of skin and subcutaneous tissue—Prednisone—ankylosing spondylitis	0.00032	0.00144	CcSEcCtD
Gemcitabine—Paraesthesia—Dexamethasone—ankylosing spondylitis	0.000318	0.00143	CcSEcCtD
Gemcitabine—Paraesthesia—Betamethasone—ankylosing spondylitis	0.000318	0.00143	CcSEcCtD
Gemcitabine—Discomfort—Prednisone—ankylosing spondylitis	0.000318	0.00143	CcSEcCtD
Gemcitabine—Erythema—Methotrexate—ankylosing spondylitis	0.000316	0.00142	CcSEcCtD
Gemcitabine—DCK—Desoximetasone—Methylprednisolone—ankylosing spondylitis	0.000309	0.026	CbGdCrCtD
Gemcitabine—Body temperature increased—Triamcinolone—ankylosing spondylitis	0.000309	0.00139	CcSEcCtD
Gemcitabine—Anaphylactic shock—Prednisone—ankylosing spondylitis	0.000309	0.00139	CcSEcCtD
Gemcitabine—Oedema—Prednisone—ankylosing spondylitis	0.000309	0.00139	CcSEcCtD
Gemcitabine—Decreased appetite—Dexamethasone—ankylosing spondylitis	0.000308	0.00138	CcSEcCtD
Gemcitabine—Decreased appetite—Betamethasone—ankylosing spondylitis	0.000308	0.00138	CcSEcCtD
Gemcitabine—Infection—Prednisone—ankylosing spondylitis	0.000307	0.00138	CcSEcCtD
Gemcitabine—Gastrointestinal disorder—Betamethasone—ankylosing spondylitis	0.000306	0.00137	CcSEcCtD
Gemcitabine—Gastrointestinal disorder—Dexamethasone—ankylosing spondylitis	0.000306	0.00137	CcSEcCtD
Gemcitabine—Back pain—Methotrexate—ankylosing spondylitis	0.000306	0.00137	CcSEcCtD
Gemcitabine—Fatigue—Betamethasone—ankylosing spondylitis	0.000306	0.00137	CcSEcCtD
Gemcitabine—Fatigue—Dexamethasone—ankylosing spondylitis	0.000306	0.00137	CcSEcCtD
Gemcitabine—DCK—Desoximetasone—Betamethasone—ankylosing spondylitis	0.000304	0.0256	CbGdCrCtD
Gemcitabine—DCK—Desoximetasone—Dexamethasone—ankylosing spondylitis	0.000304	0.0256	CbGdCrCtD
Gemcitabine—Pain—Betamethasone—ankylosing spondylitis	0.000303	0.00136	CcSEcCtD
Gemcitabine—Pain—Dexamethasone—ankylosing spondylitis	0.000303	0.00136	CcSEcCtD
Gemcitabine—Nervous system disorder—Prednisone—ankylosing spondylitis	0.000303	0.00136	CcSEcCtD
Gemcitabine—DCK—Diflorasone—Methylprednisolone—ankylosing spondylitis	0.0003	0.0253	CbGdCrCtD
Gemcitabine—Skin disorder—Prednisone—ankylosing spondylitis	0.0003	0.00135	CcSEcCtD
Gemcitabine—Hyperhidrosis—Prednisone—ankylosing spondylitis	0.000298	0.00134	CcSEcCtD
Gemcitabine—DCK—Desoximetasone—Triamcinolone—ankylosing spondylitis	0.000297	0.025	CbGdCrCtD
Gemcitabine—DCK—Diflorasone—Dexamethasone—ankylosing spondylitis	0.000295	0.0249	CbGdCrCtD
Gemcitabine—DCK—Diflorasone—Betamethasone—ankylosing spondylitis	0.000295	0.0249	CbGdCrCtD
Gemcitabine—Anorexia—Prednisone—ankylosing spondylitis	0.000294	0.00132	CcSEcCtD
Gemcitabine—Ill-defined disorder—Methotrexate—ankylosing spondylitis	0.000293	0.00132	CcSEcCtD
Gemcitabine—Anaemia—Methotrexate—ankylosing spondylitis	0.000292	0.00131	CcSEcCtD
Gemcitabine—Feeling abnormal—Dexamethasone—ankylosing spondylitis	0.000292	0.00131	CcSEcCtD
Gemcitabine—Feeling abnormal—Betamethasone—ankylosing spondylitis	0.000292	0.00131	CcSEcCtD
Gemcitabine—DCK—Diflorasone—Triamcinolone—ankylosing spondylitis	0.000288	0.0243	CbGdCrCtD
Gemcitabine—Malaise—Methotrexate—ankylosing spondylitis	0.000285	0.00128	CcSEcCtD
Gemcitabine—Leukopenia—Methotrexate—ankylosing spondylitis	0.000283	0.00127	CcSEcCtD
Gemcitabine—DCK—Desoximetasone—Prednisone—ankylosing spondylitis	0.000282	0.0238	CbGdCrCtD
Gemcitabine—Musculoskeletal discomfort—Prednisone—ankylosing spondylitis	0.000281	0.00126	CcSEcCtD
Gemcitabine—Asthenia—Triamcinolone—ankylosing spondylitis	0.00028	0.00126	CcSEcCtD
Gemcitabine—Body temperature increased—Dexamethasone—ankylosing spondylitis	0.00028	0.00126	CcSEcCtD
Gemcitabine—Body temperature increased—Betamethasone—ankylosing spondylitis	0.00028	0.00126	CcSEcCtD
Gemcitabine—Asthenia—Methylprednisolone—ankylosing spondylitis	0.00028	0.00126	CcSEcCtD
Gemcitabine—Insomnia—Prednisone—ankylosing spondylitis	0.000279	0.00125	CcSEcCtD
Gemcitabine—Paraesthesia—Prednisone—ankylosing spondylitis	0.000277	0.00125	CcSEcCtD
Gemcitabine—Pruritus—Triamcinolone—ankylosing spondylitis	0.000276	0.00124	CcSEcCtD
Gemcitabine—Cough—Methotrexate—ankylosing spondylitis	0.000276	0.00124	CcSEcCtD
Gemcitabine—Pruritus—Methylprednisolone—ankylosing spondylitis	0.000276	0.00124	CcSEcCtD
Gemcitabine—DCK—Desoximetasone—Prednisolone—ankylosing spondylitis	0.000275	0.0232	CbGdCrCtD
Gemcitabine—DCK—Diflorasone—Prednisone—ankylosing spondylitis	0.000274	0.0231	CbGdCrCtD
Gemcitabine—Arthralgia—Methotrexate—ankylosing spondylitis	0.000269	0.00121	CcSEcCtD
Gemcitabine—Chest pain—Methotrexate—ankylosing spondylitis	0.000269	0.00121	CcSEcCtD
Gemcitabine—Myalgia—Methotrexate—ankylosing spondylitis	0.000269	0.00121	CcSEcCtD
Gemcitabine—Decreased appetite—Prednisone—ankylosing spondylitis	0.000268	0.00121	CcSEcCtD
Gemcitabine—Rash—Prednisolone—ankylosing spondylitis	0.000268	0.0012	CcSEcCtD
Gemcitabine—Dermatitis—Prednisolone—ankylosing spondylitis	0.000268	0.0012	CcSEcCtD
Gemcitabine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—ankylosing spondylitis	0.000267	0.0012	CcSEcCtD
Gemcitabine—DCK—Diflorasone—Prednisolone—ankylosing spondylitis	0.000267	0.0225	CbGdCrCtD
Gemcitabine—Diarrhoea—Methylprednisolone—ankylosing spondylitis	0.000267	0.0012	CcSEcCtD
Gemcitabine—Fatigue—Prednisone—ankylosing spondylitis	0.000266	0.0012	CcSEcCtD
Gemcitabine—Headache—Prednisolone—ankylosing spondylitis	0.000266	0.0012	CcSEcCtD
Gemcitabine—Discomfort—Methotrexate—ankylosing spondylitis	0.000266	0.00119	CcSEcCtD
Gemcitabine—Constipation—Prednisone—ankylosing spondylitis	0.000264	0.00119	CcSEcCtD
Gemcitabine—Anaphylactic shock—Methotrexate—ankylosing spondylitis	0.000258	0.00116	CcSEcCtD
Gemcitabine—Infection—Methotrexate—ankylosing spondylitis	0.000256	0.00115	CcSEcCtD
Gemcitabine—Feeling abnormal—Prednisone—ankylosing spondylitis	0.000254	0.00114	CcSEcCtD
Gemcitabine—Asthenia—Dexamethasone—ankylosing spondylitis	0.000254	0.00114	CcSEcCtD
Gemcitabine—Asthenia—Betamethasone—ankylosing spondylitis	0.000254	0.00114	CcSEcCtD
Gemcitabine—Nervous system disorder—Methotrexate—ankylosing spondylitis	0.000253	0.00114	CcSEcCtD
Gemcitabine—Thrombocytopenia—Methotrexate—ankylosing spondylitis	0.000253	0.00113	CcSEcCtD
Gemcitabine—Nausea—Prednisolone—ankylosing spondylitis	0.000252	0.00113	CcSEcCtD
Gemcitabine—Pruritus—Betamethasone—ankylosing spondylitis	0.000251	0.00113	CcSEcCtD
Gemcitabine—Pruritus—Dexamethasone—ankylosing spondylitis	0.000251	0.00113	CcSEcCtD
Gemcitabine—TYMS—Clobetasol propionate—Methylprednisolone—ankylosing spondylitis	0.000251	0.0211	CbGdCrCtD
Gemcitabine—Skin disorder—Methotrexate—ankylosing spondylitis	0.000251	0.00113	CcSEcCtD
Gemcitabine—Hyperhidrosis—Methotrexate—ankylosing spondylitis	0.000249	0.00112	CcSEcCtD
Gemcitabine—Vomiting—Triamcinolone—ankylosing spondylitis	0.000248	0.00112	CcSEcCtD
Gemcitabine—Vomiting—Methylprednisolone—ankylosing spondylitis	0.000248	0.00111	CcSEcCtD
Gemcitabine—TYMS—Flunisolide—Methylprednisolone—ankylosing spondylitis	0.000247	0.0208	CbGdCrCtD
Gemcitabine—TYMS—Clobetasol propionate—Dexamethasone—ankylosing spondylitis	0.000247	0.0208	CbGdCrCtD
Gemcitabine—TYMS—Clobetasol propionate—Betamethasone—ankylosing spondylitis	0.000247	0.0208	CbGdCrCtD
Gemcitabine—Rash—Triamcinolone—ankylosing spondylitis	0.000246	0.00111	CcSEcCtD
Gemcitabine—Dermatitis—Triamcinolone—ankylosing spondylitis	0.000246	0.00111	CcSEcCtD
Gemcitabine—Anorexia—Methotrexate—ankylosing spondylitis	0.000246	0.0011	CcSEcCtD
Gemcitabine—Rash—Methylprednisolone—ankylosing spondylitis	0.000246	0.0011	CcSEcCtD
Gemcitabine—Dermatitis—Methylprednisolone—ankylosing spondylitis	0.000245	0.0011	CcSEcCtD
Gemcitabine—TYMS—Triamcinolone—Methylprednisolone—ankylosing spondylitis	0.000245	0.0206	CbGdCrCtD
Gemcitabine—Headache—Triamcinolone—ankylosing spondylitis	0.000245	0.0011	CcSEcCtD
Gemcitabine—Headache—Methylprednisolone—ankylosing spondylitis	0.000244	0.0011	CcSEcCtD
Gemcitabine—Body temperature increased—Prednisone—ankylosing spondylitis	0.000244	0.0011	CcSEcCtD
Gemcitabine—TYMS—Flunisolide—Dexamethasone—ankylosing spondylitis	0.000243	0.0205	CbGdCrCtD
Gemcitabine—TYMS—Flunisolide—Betamethasone—ankylosing spondylitis	0.000243	0.0205	CbGdCrCtD
Gemcitabine—Diarrhoea—Dexamethasone—ankylosing spondylitis	0.000242	0.00109	CcSEcCtD
Gemcitabine—Diarrhoea—Betamethasone—ankylosing spondylitis	0.000242	0.00109	CcSEcCtD
Gemcitabine—TYMS—Clobetasol propionate—Triamcinolone—ankylosing spondylitis	0.000241	0.0203	CbGdCrCtD
Gemcitabine—Hypotension—Methotrexate—ankylosing spondylitis	0.000241	0.00108	CcSEcCtD
Gemcitabine—TYMS—Triamcinolone—Dexamethasone—ankylosing spondylitis	0.000241	0.0203	CbGdCrCtD
Gemcitabine—TYMS—Triamcinolone—Betamethasone—ankylosing spondylitis	0.000241	0.0203	CbGdCrCtD
Gemcitabine—TYMS—Fluticasone Propionate—Methylprednisolone—ankylosing spondylitis	0.000239	0.0201	CbGdCrCtD
Gemcitabine—TYMS—Flunisolide—Triamcinolone—ankylosing spondylitis	0.000238	0.02	CbGdCrCtD
Gemcitabine—TYMS—Fluticasone Propionate—Betamethasone—ankylosing spondylitis	0.000235	0.0198	CbGdCrCtD
Gemcitabine—TYMS—Fluticasone Propionate—Dexamethasone—ankylosing spondylitis	0.000235	0.0198	CbGdCrCtD
Gemcitabine—Musculoskeletal discomfort—Methotrexate—ankylosing spondylitis	0.000235	0.00106	CcSEcCtD
Gemcitabine—Insomnia—Methotrexate—ankylosing spondylitis	0.000233	0.00105	CcSEcCtD
Gemcitabine—Nausea—Triamcinolone—ankylosing spondylitis	0.000232	0.00104	CcSEcCtD
Gemcitabine—Paraesthesia—Methotrexate—ankylosing spondylitis	0.000232	0.00104	CcSEcCtD
Gemcitabine—Nausea—Methylprednisolone—ankylosing spondylitis	0.000231	0.00104	CcSEcCtD
Gemcitabine—Dyspnoea—Methotrexate—ankylosing spondylitis	0.00023	0.00103	CcSEcCtD
Gemcitabine—TYMS—Fluticasone Propionate—Triamcinolone—ankylosing spondylitis	0.00023	0.0194	CbGdCrCtD
Gemcitabine—Somnolence—Methotrexate—ankylosing spondylitis	0.000229	0.00103	CcSEcCtD
Gemcitabine—TYMS—Clobetasol propionate—Prednisone—ankylosing spondylitis	0.000229	0.0193	CbGdCrCtD
Gemcitabine—TYMS—Flunisolide—Prednisone—ankylosing spondylitis	0.000226	0.019	CbGdCrCtD
Gemcitabine—TYMS—Diflorasone—Methylprednisolone—ankylosing spondylitis	0.000226	0.019	CbGdCrCtD
Gemcitabine—Vomiting—Dexamethasone—ankylosing spondylitis	0.000225	0.00101	CcSEcCtD
Gemcitabine—Vomiting—Betamethasone—ankylosing spondylitis	0.000225	0.00101	CcSEcCtD
Gemcitabine—Decreased appetite—Methotrexate—ankylosing spondylitis	0.000224	0.00101	CcSEcCtD
Gemcitabine—TYMS—Triamcinolone—Prednisone—ankylosing spondylitis	0.000223	0.0188	CbGdCrCtD
Gemcitabine—Rash—Betamethasone—ankylosing spondylitis	0.000223	0.001	CcSEcCtD
Gemcitabine—Rash—Dexamethasone—ankylosing spondylitis	0.000223	0.001	CcSEcCtD
Gemcitabine—TYMS—Clobetasol propionate—Prednisolone—ankylosing spondylitis	0.000223	0.0188	CbGdCrCtD
Gemcitabine—Dermatitis—Betamethasone—ankylosing spondylitis	0.000223	0.001	CcSEcCtD
Gemcitabine—Dermatitis—Dexamethasone—ankylosing spondylitis	0.000223	0.001	CcSEcCtD
Gemcitabine—Gastrointestinal disorder—Methotrexate—ankylosing spondylitis	0.000223	0.001	CcSEcCtD
Gemcitabine—Fatigue—Methotrexate—ankylosing spondylitis	0.000222	0.000999	CcSEcCtD
Gemcitabine—TYMS—Diflorasone—Betamethasone—ankylosing spondylitis	0.000222	0.0187	CbGdCrCtD
Gemcitabine—TYMS—Diflorasone—Dexamethasone—ankylosing spondylitis	0.000222	0.0187	CbGdCrCtD
Gemcitabine—Headache—Betamethasone—ankylosing spondylitis	0.000222	0.000998	CcSEcCtD
Gemcitabine—Headache—Dexamethasone—ankylosing spondylitis	0.000222	0.000998	CcSEcCtD
Gemcitabine—Asthenia—Prednisone—ankylosing spondylitis	0.000221	0.000995	CcSEcCtD
Gemcitabine—Pain—Methotrexate—ankylosing spondylitis	0.000221	0.000991	CcSEcCtD
Gemcitabine—TYMS—Flunisolide—Prednisolone—ankylosing spondylitis	0.00022	0.0186	CbGdCrCtD
Gemcitabine—Pruritus—Prednisone—ankylosing spondylitis	0.000218	0.000981	CcSEcCtD
Gemcitabine—TYMS—Triamcinolone—Prednisolone—ankylosing spondylitis	0.000218	0.0184	CbGdCrCtD
Gemcitabine—TYMS—Diflorasone—Triamcinolone—ankylosing spondylitis	0.000217	0.0183	CbGdCrCtD
Gemcitabine—Feeling abnormal—Methotrexate—ankylosing spondylitis	0.000213	0.000955	CcSEcCtD
Gemcitabine—Diarrhoea—Prednisone—ankylosing spondylitis	0.000211	0.000949	CcSEcCtD
Gemcitabine—Nausea—Dexamethasone—ankylosing spondylitis	0.00021	0.000946	CcSEcCtD
Gemcitabine—Nausea—Betamethasone—ankylosing spondylitis	0.00021	0.000946	CcSEcCtD
Gemcitabine—TYMS—Diflorasone—Prednisone—ankylosing spondylitis	0.000206	0.0174	CbGdCrCtD
Gemcitabine—Body temperature increased—Methotrexate—ankylosing spondylitis	0.000204	0.000916	CcSEcCtD
Gemcitabine—TYMS—Diflorasone—Prednisolone—ankylosing spondylitis	0.000201	0.0169	CbGdCrCtD
Gemcitabine—TYMS—Budesonide—Methylprednisolone—ankylosing spondylitis	0.000198	0.0167	CbGdCrCtD
Gemcitabine—Vomiting—Prednisone—ankylosing spondylitis	0.000196	0.000882	CcSEcCtD
Gemcitabine—TYMS—Budesonide—Dexamethasone—ankylosing spondylitis	0.000195	0.0164	CbGdCrCtD
Gemcitabine—TYMS—Budesonide—Betamethasone—ankylosing spondylitis	0.000195	0.0164	CbGdCrCtD
Gemcitabine—Rash—Prednisone—ankylosing spondylitis	0.000195	0.000874	CcSEcCtD
Gemcitabine—Dermatitis—Prednisone—ankylosing spondylitis	0.000194	0.000874	CcSEcCtD
Gemcitabine—Headache—Prednisone—ankylosing spondylitis	0.000193	0.000869	CcSEcCtD
Gemcitabine—TYMS—Budesonide—Triamcinolone—ankylosing spondylitis	0.00019	0.016	CbGdCrCtD
Gemcitabine—Asthenia—Methotrexate—ankylosing spondylitis	0.000185	0.000832	CcSEcCtD
Gemcitabine—Nausea—Prednisone—ankylosing spondylitis	0.000183	0.000824	CcSEcCtD
Gemcitabine—Pruritus—Methotrexate—ankylosing spondylitis	0.000182	0.00082	CcSEcCtD
Gemcitabine—TYMS—Budesonide—Prednisone—ankylosing spondylitis	0.000181	0.0152	CbGdCrCtD
Gemcitabine—Diarrhoea—Methotrexate—ankylosing spondylitis	0.000176	0.000793	CcSEcCtD
Gemcitabine—TYMS—Budesonide—Prednisolone—ankylosing spondylitis	0.000176	0.0149	CbGdCrCtD
Gemcitabine—TYMS—Danazol—Prednisone—ankylosing spondylitis	0.000173	0.0146	CbGdCrCtD
Gemcitabine—Vomiting—Methotrexate—ankylosing spondylitis	0.000164	0.000737	CcSEcCtD
Gemcitabine—Rash—Methotrexate—ankylosing spondylitis	0.000163	0.000731	CcSEcCtD
Gemcitabine—Dermatitis—Methotrexate—ankylosing spondylitis	0.000162	0.00073	CcSEcCtD
Gemcitabine—Headache—Methotrexate—ankylosing spondylitis	0.000162	0.000726	CcSEcCtD
Gemcitabine—Nausea—Methotrexate—ankylosing spondylitis	0.000153	0.000688	CcSEcCtD
